Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
AR protein | 24 | 0 | 0 | 24 |
retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
estrogen nuclear receptor alpha | 34 | 0 | 0 | 34 |
thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
thyroid hormone receptor beta isoform 2 | 19 | 0 | 0 | 19 |
Voltage-dependent calcium channel gamma-2 subunit | 10 | 0 | 0 | 10 |
Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 2 | 0 | 2 |
Glutamate receptor 2 | 10 | 0 | 0 | 10 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 2 | 1 | 5 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 0 | 1 | 1 |
Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
Luciferase | 9 | 0 | 0 | 9 |
acetylcholinesterase | 10 | 0 | 0 | 10 |
hypoxia-inducible factor 1 alpha subunit | 10 | 0 | 0 | 10 |
RAR-related orphan receptor gamma | 18 | 0 | 0 | 18 |
estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
progesterone receptor | 16 | 0 | 0 | 16 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
EWS/FLI fusion protein | 20 | 0 | 0 | 20 |
farnesoid X nuclear receptor | 14 | 0 | 0 | 14 |
G | 18 | 0 | 0 | 18 |
cytochrome P450 2D6 | 13 | 0 | 0 | 13 |
peroxisome proliferator-activated receptor delta | 15 | 0 | 0 | 15 |
peroxisome proliferator activated receptor gamma | 16 | 0 | 0 | 16 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 14 | 0 | 0 | 14 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
Histone H2A.x | 11 | 0 | 0 | 11 |
heat shock protein beta-1 | 8 | 0 | 0 | 8 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 18 | 0 | 0 | 18 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 5 |
Solute carrier organic anion transporter family member 2B1 | 0 | 5 | 0 | 5 |
Interferon beta | 21 | 0 | 0 | 21 |
HLA class I histocompatibility antigen, B alpha chain | 18 | 0 | 0 | 18 |
Replicase polyprotein 1ab | 0 | 6 | 2 | 8 |
Replicase polyprotein 1ab | 0 | 11 | 3 | 14 |
Thrombopoietin receptor | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 23 | 1 | 27 |
Sodium channel protein type 5 subunit alpha | 0 | 5 | 0 | 5 |
Inositol hexakisphosphate kinase 1 | 18 | 0 | 0 | 18 |
Solute carrier organic anion transporter family member 1B3 | 0 | 6 | 0 | 7 |
Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 10 | 1 | 11 |
Solute carrier organic anion transporter family member 1B1 | 0 | 8 | 0 | 9 |
cytochrome P450 2C9, partial | 18 | 0 | 0 | 18 |
peripheral myelin protein 22 | 11 | 0 | 0 | 11 |
histone acetyltransferase KAT2A isoform 1 | 12 | 0 | 0 | 12 |
lamin isoform A-delta10 | 16 | 0 | 0 | 16 |
ATP-binding cassette sub-family C member 3 | 0 | 28 | 0 | 28 |
Multidrug resistance-associated protein 4 | 0 | 28 | 0 | 28 |
Bile salt export pump | 0 | 39 | 0 | 39 |
Canalicular multispecific organic anion transporter 1 | 0 | 27 | 0 | 27 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, 2-oxoglutarate Oxygenase | 13 | 0 | 0 | 13 |
Microtubule-associated protein tau | 10 | 0 | 0 | 10 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
Smad3 | 9 | 0 | 0 | 9 |
euchromatic histone-lysine N-methyltransferase 2 | 20 | 0 | 0 | 20 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 2 | 0 | 5 | 0 | 6 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 1 | 1 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
Chain A, Beta-lactamase | 6 | 0 | 0 | 6 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 1 | 0 | 3 |
apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 8 | 0 | 0 | 8 |
urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
plasminogen precursor | 4 | 0 | 0 | 4 |
urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
Bile salt export pump | 0 | 12 | 0 | 12 |
Beta-lactamase SHV-1 | 0 | 1 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 2 | 0 | 5 |
Cytochrome P450 2C9 | 0 | 14 | 0 | 15 |
Beta-lactamase | 0 | 1 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 11 | 1 | 13 |
Cytochrome P450 3A4 | 0 | 15 | 0 | 17 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Cytochrome P450 2D6 | 0 | 9 | 1 | 11 |
Cytochrome P450 2B6 | 0 | 3 | 1 | 5 |
Cytochrome P450 2C19 | 0 | 9 | 0 | 10 |
Spike glycoprotein | 14 | 2 | 2 | 18 |
ATP synthase subunit c | 0 | 0 | 1 | 1 |
ATP synthase subunit c | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
TDP1 protein | 24 | 0 | 0 | 24 |
GLI family zinc finger 3 | 23 | 0 | 0 | 23 |
glucocorticoid receptor [Homo sapiens] | 24 | 0 | 0 | 24 |
retinoid X nuclear receptor alpha | 15 | 0 | 0 | 15 |
estrogen-related nuclear receptor alpha | 19 | 0 | 0 | 19 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 13 | 0 | 0 | 13 |
nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
Cellular tumor antigen p53 | 15 | 0 | 0 | 15 |
ATPase family AAA domain-containing protein 5 | 11 | 0 | 0 | 11 |
Ataxin-2 | 13 | 0 | 0 | 13 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 6 | 0 | 0 | 6 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
nuclear receptor ROR-gamma isoform 1 | 12 | 0 | 0 | 12 |
Carbonic anhydrase 12 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 2 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 9 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 2 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
thioredoxin reductase | 8 | 0 | 0 | 8 |
phosphopantetheinyl transferase | 10 | 0 | 0 | 10 |
ATAD5 protein, partial | 3 | 0 | 0 | 3 |
Fumarate hydratase | 6 | 0 | 0 | 6 |
USP1 protein, partial | 11 | 0 | 0 | 11 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
nuclear receptor subfamily 1, group I, member 3 | 13 | 0 | 0 | 13 |
NADPH oxidase 1 | 0 | 2 | 0 | 2 |
pregnane X nuclear receptor | 17 | 0 | 0 | 17 |
polyprotein | 6 | 0 | 0 | 6 |
67.9K protein | 7 | 0 | 0 | 7 |
Snq2p | 0 | 0 | 0 | 3 |
caspase-3 | 6 | 0 | 0 | 6 |
IDH1 | 6 | 0 | 0 | 6 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Caspase-7 | 4 | 0 | 0 | 4 |
Spike glycoprotein | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 3 | 2 | 5 |
cytochrome P450 2D6 isoform 1 | 3 | 0 | 0 | 3 |
cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
vitamin D3 receptor isoform VDRA | 12 | 0 | 0 | 12 |
chromobox protein homolog 1 | 13 | 0 | 0 | 13 |
potassium voltage-gated channel subfamily H member 2 isoform d | 11 | 0 | 0 | 11 |
caspase-3 | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 5 | 0 | 0 | 5 |
mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
ras-related protein Rab-9A | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
geminin | 17 | 0 | 0 | 17 |
survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
lethal factor (plasmid) | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit pi | 9 | 3 | 0 | 12 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 4 | 0 | 0 | 4 |
Transmembrane protease serine 2 | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 6 | 11 |
Albumin | 0 | 0 | 3 | 3 |
Major prion protein | 0 | 0 | 1 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Integrin beta-3 | 3 | 0 | 0 | 3 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Procathepsin L | 0 | 2 | 2 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 0 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 18 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
Integrin alpha-IIb | 3 | 0 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 8 | 0 | 8 |
Replicase polyprotein 1a | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme | 0 | 6 | 0 | 6 |
D(2) dopamine receptor | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 3 | 0 | 12 |
Alpha-1B adrenergic receptor | 0 | 10 | 0 | 10 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 3 | 0 | 12 |
Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
D | 0 | 3 | 0 | 3 |
D(3) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 1 | 8 |
Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 3 | 0 | 12 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 0 | 6 | 0 | 7 |
D(4) dopamine receptor | 0 | 6 | 0 | 7 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 3 | 0 | 12 |
Alpha-1D adrenergic receptor | 0 | 6 | 0 | 6 |
Sodium-dependent noradrenaline transporter | 0 | 8 | 0 | 8 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 0 | 6 | 0 | 6 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 2C | 0 | 8 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 3 | 0 | 12 |
5-hydroxytryptamine receptor 1B | 0 | 6 | 0 | 6 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 3 | 0 | 12 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 1 | 2 |
Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 3 | 0 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
D(3) dopamine receptor | 0 | 8 | 0 | 9 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 8 | 0 | 8 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 10 | 0 | 10 |
Histamine H2 receptor | 6 | 0 | 0 | 6 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 2 | 3 |
D(2) dopamine receptor | 0 | 5 | 0 | 6 |
Calmodulin | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 3 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 3 | 0 | 12 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
Sodium-dependent dopamine transporter | 0 | 8 | 0 | 8 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 2 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 6 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 6 | 0 | 6 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
GABA theta subunit | 9 | 3 | 0 | 12 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 9 | 3 | 0 | 12 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
Chain A, Cruzipain | 5 | 0 | 0 | 5 |
aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 6 | 0 | 0 | 6 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 2 | 0 | 4 |
DNA gyrase subunit A | 0 | 6 | 0 | 10 |
DNA gyrase subunit B | 0 | 6 | 0 | 10 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 3 |
DNA topoisomerase 4 subunit A | 0 | 3 | 0 | 5 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 6 |
DNA gyrase subunit A | 0 | 2 | 0 | 4 |
Multidrug resistance protein MdtK | 0 | 0 | 2 | 2 |
DNA gyrase subunit B | 0 | 5 | 0 | 7 |
DNA gyrase subunit A | 0 | 7 | 0 | 9 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 7 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
snurportin-1 | 2 | 0 | 0 | 2 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
streptokinase A precursor | 0 | 0 | 7 | 7 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Beta-lactamase OXA-1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 2 | 0 | 5 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Class D beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Metallo-b-lactamase | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 1 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 2 | 0 | 4 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 5 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
mitogen-activated protein kinase kinase kinase kinase 2 isoform 1 | 0 | 0 | 1 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
mitogen-activated protein kinase kinase kinase 3 isoform 1 | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 2 | 2 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Cruzipain | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 2 | 2 |
pregnane X receptor | 2 | 0 | 0 | 2 |
GALC protein | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
Exportin-1 | 0 | 1 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 3 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
Cytochrome P450 2A5 | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 2 |
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 0 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Quinone oxidoreductase | 0 | 0 | 0 | 1 |
Beta-secretase 1 | 0 | 1 | 0 | 1 |
Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 2 | 0 | 2 |
Zn finger protein | 0 | 1 | 0 | 1 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
Bloom syndrome protein isoform 1 | 2 | 0 | 0 | 2 |
D-alanine--D-alanine ligase | 0 | 1 | 0 | 1 |
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | 0 | 1 | 0 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
Deoxycytidine kinase | 0 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
15-lipoxygenase, partial | 5 | 0 | 0 | 5 |
SMAD family member 2 | 8 | 0 | 0 | 8 |
GLS protein | 7 | 0 | 0 | 7 |
PPM1D protein | 5 | 0 | 0 | 5 |
SMAD family member 3 | 8 | 0 | 0 | 8 |
hypothetical protein, conserved | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 1 | 0 | 0 | 1 |
pyruvate kinase | 2 | 0 | 0 | 2 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
LacZ protein (plasmid) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
activating transcription factor 6 | 6 | 0 | 0 | 6 |
thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
runt-related transcription factor 1 isoform AML1b | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 2 | 0 | 0 | 2 |
huntingtin isoform 2 | 7 | 0 | 0 | 7 |
polypyrimidine tract-binding protein 1 isoform a | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
apelin receptor | 0 | 1 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Vpr | 3 | 0 | 0 | 3 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Carbamate kinase | 0 | 1 | 0 | 1 |
Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
Amyloid-beta precursor protein | 1 | 0 | 0 | 1 |
Aldehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A3 | 0 | 4 | 0 | 4 |
Amine oxidase [flavin-containing] A | 0 | 6 | 0 | 6 |
C-X-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
Lysine-specific demethylase 5A | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 2 | 0 | 2 |
Alpha-synuclein | 1 | 4 | 0 | 5 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 4 | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 5 | 0 | 2 | 0 | 2 |
Gasdermin-D | 0 | 2 | 0 | 2 |
Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
Monoglyceride lipase | 0 | 1 | 0 | 1 |
Gasdermin-D | 0 | 2 | 0 | 2 |
Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain B, POL POLYPROTEIN | 0 | 1 | 0 | 1 |
Chain A, Pol Polyprotein | 0 | 1 | 0 | 1 |
Chain B, Pol Polyprotein | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Gag-Pol polyprotein | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 0 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Microsomal triglyceride transfer protein large subunit | 0 | 1 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 0 | 1 | 0 | 1 |
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 3 | 1 | 9 |
Protease | 0 | 4 | 2 | 9 |
Fructose-1,6-bisphosphatase 1 | 0 | 0 | 0 | 1 |
Reverse transcriptase | 0 | 1 | 1 | 2 |
Cholesterol 24-hydroxylase | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 2 |
Catechol O-methyltransferase | 0 | 3 | 0 | 3 |
Catechol O-methyltransferase | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B15 | 0 | 0 | 0 | 2 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Pantothenate synthetase | 0 | 2 | 0 | 2 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
glp-1 receptor, partial | 3 | 0 | 0 | 3 |
WRN | 1 | 0 | 0 | 1 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase NSD2 isoform 1 | 0 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
10 kDa chaperonin | 0 | 2 | 0 | 2 |
putative polyprotein | 0 | 1 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
DNA polymerase beta | 4 | 0 | 0 | 4 |
Polyphenol oxidase 2 | 0 | 3 | 0 | 5 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
unnamed protein product | 0 | 1 | 0 | 1 |
bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
Histone deacetylase 3 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
Chymotrypsinogen A | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Aromatase | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 4 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Histone deacetylase 4 | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Mycocyclosin synthase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 1 | 3 |
Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Sterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
Histone deacetylase 7 | 0 | 1 | 0 | 1 |
Histone deacetylase 2 | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
Histone deacetylase 11 | 0 | 1 | 0 | 1 |
14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
Histone deacetylase 8 | 0 | 1 | 0 | 1 |
Histone deacetylase 6 | 0 | 1 | 0 | 1 |
Histone deacetylase 9 | 0 | 1 | 0 | 1 |
Histone deacetylase 5 | 0 | 1 | 0 | 1 |
likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
arylsulfatase A | 4 | 0 | 0 | 4 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 3 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Metallo-beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 1 | 3 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
BlaVIM-1 | 0 | 0 | 0 | 2 |
Histamine H3 receptor | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
Isocitrate lyase | 0 | 1 | 0 | 1 |
Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
Gap junction alpha-1 protein | 0 | 1 | 0 | 1 |
Gap junction beta-2 protein | 0 | 1 | 0 | 1 |
Acyl-protein thioesterase 1 | 0 | 1 | 0 | 1 |
CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
Tubulin beta-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta chain | 0 | 1 | 0 | 1 |
Tubulin alpha-3C chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1B chain | 0 | 1 | 0 | 1 |
Tubulin alpha-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta-4B chain | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
DNA primase | 0 | 1 | 0 | 1 |
Tubulin beta-3 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2A chain | 0 | 1 | 0 | 1 |
Tubulin beta-8 chain | 0 | 1 | 0 | 1 |
Tubulin alpha-3E chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Tubulin alpha-1C chain | 0 | 1 | 0 | 1 |
Tubulin beta-6 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Tubulin beta-1 chain | 0 | 1 | 0 | 1 |
30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 0 | 1 |
Renin | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 1 | 0 | 1 |
Chain B, protease | 0 | 1 | 0 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, protease | 0 | 0 | 1 | 1 |
Chain B, protease | 0 | 0 | 1 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, Protease | 0 | 1 | 0 | 1 |
Chain B, Protease | 0 | 1 | 0 | 1 |
Chain A, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain B, PROTEASE RETROPEPSIN | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain A, Protease Retropepsin | 0 | 1 | 0 | 1 |
Chain B, Protease Retropepsin | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
Gag-Pol polyprotein | 0 | 2 | 0 | 2 |
CAAX prenyl protease 1 homolog | 0 | 1 | 0 | 1 |
Plasmepsin V | 0 | 2 | 0 | 2 |
Protease | 0 | 4 | 3 | 7 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 2 | 0 | 2 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 2 | 0 | 2 |
Matrix metalloproteinase-9 | 0 | 1 | 0 | 1 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 1 | 0 | 1 |
Pyruvate-flavodoxin oxidoreductase | 0 | 1 | 0 | 1 |
Anoctamin-1 | 0 | 1 | 0 | 1 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Trypsin | 0 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Decaprenylphosphoryl-beta-D-ribose oxidase | 0 | 1 | 0 | 2 |
interleukin 8 | 2 | 0 | 0 | 2 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
rac GTPase-activating protein 1 isoform a | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 2 | 0 | 2 |
Glucocorticoid receptor | 0 | 2 | 1 | 8 |
Progesterone receptor | 0 | 2 | 0 | 3 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Androgen receptor | 0 | 1 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 2 | 0 | 2 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-6 | 0 | 2 | 0 | 2 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Hydroxycarboxylic acid receptor 2 | 0 | 0 | 1 | 1 |
Pyridoxal kinase | 0 | 0 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Chain A, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain B, HIV-1 PROTEASE | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, POL polyprotein | 0 | 1 | 0 | 1 |
Chain B, POL polyprotein | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Chain A, Endothiapepsin | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
Thromboxane-A synthase | 0 | 0 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
4,4'-diapophytoene synthase | 0 | 2 | 0 | 2 |
Geranylgeranyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Squalene synthase | 0 | 2 | 0 | 2 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Cathepsin D | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 1 | 0 | 1 |
Transthyretin | 0 | 1 | 1 | 2 |
Genome polyprotein | 0 | 1 | 1 | 2 |
Krueppel-like factor 10 | 0 | 1 | 0 | 1 |
Chain A, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Purine nucleoside phosphorylase DeoD-type | 0 | 1 | 0 | 1 |
NS5 | 0 | 0 | 1 | 1 |
MSH | 0 | 0 | 0 | 1 |
Hsf1 protein | 0 | 0 | 1 | 2 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
Adenosine kinase | 0 | 1 | 0 | 1 |
Programmed cell death protein 4 | 0 | 1 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
Glycoprotein | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 2 | 1 | 4 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |